Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507692-21-00

Acronym

RAY902CT

Enrollment

Registered

2024-07-09

Start date

2024-08-22

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiphospholipid syndrome, Behçet’s Syndrome, Bullous pemphigoid, Dermatomyositis, Immune-mediated necrotizing myopathy, Immune Thrombocytopenia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026